Senior insider sale
Chief Medical Officer at ADAPTIMMUNE THERAPEUTICS PLC — senior position signals high conviction
$12.9K
22.20K shares
What this filing means
NORRY ELLIOT plans to sell 22.20K shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $12.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/15/2025ACC: 0001970051-25-000003
Officer· Chief Medical Officer
Since Jan 2020
22.20K
Shares to sell
$12.9K
Approx. market value
22.20K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months2
Sell to cover exercise (cashless)
COMPENSATION
1/15/2025
9.80KSell to cover exercise (cashless)
Compensation
1/13/2025
12.39KTotal acquired22.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2025 | Sell to cover exercise (cashless) COMPENSATION | 9.80K | — |
1/13/2025 | Sell to cover exercise (cashless) Compensation | 12.39K | — |
| Total | 22.20K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
9.80K
Market value
$5.6K
1/15/2025
NASDAQPlanned
Units to sell
12.39K
Market value
$7.3K
1/13/2025
Total
Units
22.20K
Value
$12.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/15/2025 | 9.80K | $5.6K | NASDAQ | Planned |
1/13/2025 | 12.39K | $7.3K | NASDAQ | Planned |
| Total | 22.20K | $12.9K | ||